Cost-effectiveness analysis of Shexiang Baoxin Pill (MUSKARDIA) as the add-on treatment to standard therapy for stable coronary artery disease in China
Article in PLOS ONE (March 2024)
The most recent citing publications are shown below. View all 179 publications that cite this research output on Dimensions.
Article in PLOS ONE (March 2024)
Article in Medical Decision Making (January 2024)
Preprint in medRxiv (November 2023)